Phanes Therapeutics
Clinical trials sponsored by Phanes Therapeutics, explained in plain language.
-
New hope for tough cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis is an early-stage study testing a new drug called Spevatamig (PT886) in people with advanced cancers of the stomach, pancreas, and bile ducts. The main goals are to find a safe dose and see how well the body handles the drug. It will be tested alone and in combination with s…
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for Tough-to-Treat cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis early-stage study is testing a new drug called PT217 for people with advanced neuroendocrine cancers that have spread or come back after standard treatments. Researchers will first find the safest dose of PT217 given alone, then test it combined with chemotherapy. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC